Published November 21, 2012 | Version Supplemental Material + Accepted Version
Journal Article Open

The Reaction Mechanism of the Enantioselective Tsuji Allylation: Inner-Sphere and Outer-Sphere Pathways, Internal Rearrangements, and Asymmetric C–C Bond Formation

Abstract

We use first principles quantum mechanics (density functional theory) to report a detailed reaction mechanism of the asymmetric Tsuji allylation involving prochiral nucleophiles and nonprochiral allyl fragments, which is consistent with experimental findings. The observed enantioselectivity is best explained with an inner-sphere mechanism involving the formation of a 5-coordinate Pd species that undergoes a ligand rearrangement, which is selective with regard to the prochiral faces of the intermediate enolate. Subsequent reductive elimination generates the product and a Pd^0 complex. The reductive elimination occurs via an unconventional seven-centered transition state that contrasts dramatically with the standard three-centered C–C reductive elimination mechanism. Although limitations in the present theory prevent the conclusive identification of the enantioselective step, we note that three different computational schemes using different levels of theory all find that inner-sphere pathways are lower in energy than outer-sphere pathways. This result qualitatively contrasts with established allylation reaction mechanisms involving prochiral nucleophiles and prochiral allyl fragments. Energetic profiles of all reaction pathways are presented in detail.

Additional Information

© 2012 American Chemical Society. Received: July 19, 2012; published: October 28, 2012. We thank K. Tani, A. Harned, and J. Enquist for experimental collaboration and discussion, and M. Day and L. Henling for crystallography assistance. J.A.K. thanks A. Tkatchenko for discussions and calculations with dispersion-corrected DFT. This research was partly funded by Chevron-Texaco, and the facilities used were funded by grants from ARO−DURIP, ONR-DURIP, IBM-SUR, Fannie and John Hertz Foundation (D.C.B.), and Eli Lilly (J.T.M.) with additional support from NSF (CTS-0608889 and CHE-1214158, W.A.G.) and NIHNIGMS (R01GM080269-01, B.M.S.).

Attached Files

Accepted Version - nihms420064.pdf

Supplemental Material - ja306860n_si_001.pdf

Supplemental Material - ja306860n_si_002.cif

Files

ja306860n_si_001.pdf

Files (4.6 MB)

Name Size Download all
md5:fa532099c94696daa08c9f8ef45c1250
437.4 kB Preview Download
md5:5046abb31cd7498eca7575870dd77d8c
10.0 kB Download
md5:474c96cd2104a3cde9cd34f4d01d432e
4.1 MB Preview Download

Additional details

Identifiers

PMCID
PMC3537505
Eprint ID
36359
DOI
10.1021/ja306860n
Resolver ID
CaltechAUTHORS:20130114-141639858

Related works

Describes
10.1021/ja306860n (DOI)

Funding

Chevron-Texaco
Army Research Office (ARO)
Office of Naval Research (ONR)
IBM Corp.
Fannie and John Hertz Foundation
Eli Lilly
NSF
CTS-0608889
NSF
CHE-1214158
NIH
R01GM080269-01

Dates

Created
2013-01-14
Created from EPrint's datestamp field
Updated
2021-11-09
Created from EPrint's last_modified field